Stock Analiz

MDLN vs RMD stock comparison

Medline vs. Resmed · data as of November 13, 2026

Medline (MDLN) has a market value of about $51.9B, Resmed (RMD) about $33.7B. Over their latest twelve months Medline had revenue of $30.7B and Resmed $5.7B.

On our five checks Resmed scores higher: 4.2 out of 5 (excellent) against 1.0 (weak).

By area, the stronger company is Resmed on value; Resmed on future growth; Resmed on track record; Resmed on financial health; Resmed on shareholder returns.

Resmed is cheaper on earnings (P/E 21.8 vs. 89.7).

Medline leads on 4 of the compared lines and Resmed on 18.

Side by side

MDLNRMD
Size and price
Market cap$51.9B$33.7B
Share price$39.47$239.53
Score
Overall score (of 5)1.04.2
Value03
Future growth24
Track record05
Financial health25
Shareholder returns14
Valuation
P/E (TTM)89.721.8
Forward P/E26.218.9
Price / free cash flow27.420.9
Price / sales1.75.9
EV / EBITDA22.615.9
PEG—0.83
DCF value vs. price−48%−28%
Business
Revenue$30.7B$5.7B
Net income$566M$1.6B
Free cash flow$1.9B$1.6B
Net margin1.8%27.8%
Gross margin (5-yr avg.)26.4%57.9%
ROIC (5-yr avg.)8.6%18.9%
Growth
Revenue growth (1 yr)11.5%9.8%
Revenue growth (5 yrs, per year)—12.1%
EPS growth (5 yrs, per year)—26.3%
Balance sheet and payouts
Net cash (cash minus debt)-$9.1B$400M
Dividend yieldNone1.10%
Shareholder yield0.1%3.2%
Analysts
Upside to average target+15%+10%
Consensus ratingBuyBuy

Highlighted = the better figure on that line. Revenue, net income and free cash flow: MDLN TTM to September 30, 2026, RMD TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, Medline or Resmed?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Resmed scores 4.2 out of 5 and Medline 1.0; the table shows where each one is stronger.

Is Medline cheaper than Resmed?

On trailing earnings, Resmed trades at a P/E of 21.8 and Medline at 89.7, so Resmed is cheaper by this measure. A lower P/E can also reflect slower expected growth.

Which pays a higher dividend?

Medline yields nothing (no dividend) and Resmed 1.10%.

Full Medline analysis → Full Resmed analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.